Business & Finance
RaySearch Laboratories reports Yonsei Cancer Centre in South Korea first clinic in Asia-Pacific to choose RayCare and RayStation
21 February 2020 -

Medical technology company RaySearch Laboratories AB (STO:RAYB) announced on Thursday that Yonsei Cancer Centre in Seoul, South Korea is the first clinic in the Asia-Pacific region to adopt oncology information system RayCare. Also, this centre has ordered an additional RayStation system for carbon-ion radiation therapy treatment planning.

The total order value, excluding service agreement, is approximately EUR3.3m, of which about EUR1m was recognised as revenues by the company in the fourth quarter of 2019.

According to the company, RayCare was developed to meet the complex logistical challenges of current day cancer centres. It combines multiple software systems for radiation, medical and surgical oncology into a single, harmonised system. Integrating activities and workflows saves time, reduces complications and minimises the risk of error.

Yonsei is the first cancer centre in the Asia-Pacific region to use RayCare, which is currently in clinical use at Heidelberg University Hospital in Germany, Iridium Cancer Network in Belgium and a Provision CARES Proton Therapy Centre in the US.

In addition, Yonsei is also currently installing a carbon-ion therapy system from Toshiba Energy Systems & Solutions and has placed an order for RayStation. After Yamagata University Hospital in Japan, Yonsei is the second centre in the world to choose RayStation in combination with Toshiba's carbon-ion system. The centre currently uses RayStation for photon treatment planning.

RaySearch Laboratories develops innovative software solutions to improve cancer care. The company markets the RayStation treatment planning system and RayCare, the next-generation oncology information system, worldwide.